1. Home
  2. NUAI vs AKBA Comparison

NUAI vs AKBA Comparison

Compare NUAI & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Era Energy & Digital Inc.

NUAI

New Era Energy & Digital Inc.

HOLD

Current Price

$4.84

Market Cap

403.6M

Sector

Energy

ML Signal

HOLD

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

N/A

Current Price

$0.90

Market Cap

343.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NUAI
AKBA
Founded
N/A
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
403.6M
343.4M
IPO Year
2024
2014

Fundamental Metrics

Financial Performance
Metric
NUAI
AKBA
Price
$4.84
$0.90
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$11.00
$4.67
AVG Volume (30 Days)
5.5M
5.4M
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
1.89
93.94
EPS
N/A
N/A
Revenue
$885,400.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
66.18
N/A
52 Week Low
$0.32
$0.81
52 Week High
$9.45
$3.22

Technical Indicators

Market Signals
Indicator
NUAI
AKBA
Relative Strength Index (RSI) 45.92 36.01
Support Level $4.13 $0.84
Resistance Level $5.31 $1.54
Average True Range (ATR) 0.50 0.06
MACD -0.03 -0.01
Stochastic Oscillator 15.00 15.86

Price Performance

Historical Comparison
NUAI
AKBA

About NUAI New Era Energy & Digital Inc.

New Era Energy & Digital Inc is engaged into a fully integrated energy supplier delivering next-gen digital infrastructure and power assets. The company provides turnkey solutions to speed up data center deployment and reduce costs. The company focuses on future-proofing infrastructure for hyperscale, enterprise, and edge operators. The company provide integrated energy and digital solutions to support accelerating AI infrastructure deployment and optimize data center investments.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

Share on Social Networks: